VEGFA and glioblastoma: However, the pro-invasive phenotype observed in siTRPML2, compared with siGLO cells, may be a result of VEGFA/VEGFR2 pathway downregulation, which stimulates the EMT process in GBM cell lines, resulting in the acquisition of a more invasive mesenchymal phenotype [38,39].